EC Number   |
Inhibitors |
Structure |
|---|
   3.1.1.55 | 4-bis-nitrophenyl phosphate |
- |
   |
| 3.1.1.55 | bis(4-nitrophenyl)hydrogen phosphate |
irreversible, complete inhibition |
|
| 3.1.1.55 | bis(4-nitrophenyl)hydrogen phosphate |
i.e. BNPP, organophosphate carboxylesterase inhibitor, enzymes from intestinal and gastric mucosa are inhibited by 80% at 0.1 mM, while the liver enzyme shows only 25% inhibition |
|
| 3.1.1.55 | bis-4-nitrophenyl phosphate |
- |
|
| 3.1.1.55 | eserine |
selective for aspirin esterase II |
|
| 3.1.1.55 | methoxy arachidonyl fluorophosphonate |
type 1 PAF acetylhydrolase is irreversibly inhibited |
|
| 3.1.1.55 | more |
substrate inhibition increases with increasing chain length of the fatty acid on the ester |
|
| 3.1.1.55 | NaF |
- |
|
| 3.1.1.55 | paraoxon |
complete inhibition at 0.1 mM |
|
| 3.1.1.55 | platelet activating factor |
competitive |
|
